3,841 Shares in Agilent Technologies, Inc. $A Acquired by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,841 shares of the medical research company’s stock, valued at approximately $510,000.

A number of other institutional investors have also recently added to or reduced their stakes in A. State Street Corp lifted its stake in Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after buying an additional 241,029 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Agilent Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after acquiring an additional 25,139 shares during the period. Deutsche Bank AG increased its holdings in shares of Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares during the period. Bank of New York Mellon Corp lifted its position in Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after purchasing an additional 2,440,360 shares during the last quarter. Finally, Morgan Stanley boosted its stake in Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after purchasing an additional 692,202 shares during the period.

Agilent Technologies Stock Performance

A opened at $155.16 on Thursday. The company has a market capitalization of $43.82 billion, a price-to-earnings ratio of 31.16, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.51. The business has a 50 day moving average price of $139.16 and a two-hundred day moving average price of $126.65.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same period last year, the firm earned $1.37 EPS. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts predict that Agilent Technologies, Inc. will post 6.05 EPS for the current fiscal year.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. TD Cowen raised their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Robert W. Baird increased their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Finally, Royal Bank Of Canada assumed coverage on Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.